Comments
Description
Transcript
Formato - Assolombarda
Global Pharmaceutical Perspective Daniel VIAL Vicepresidente IMS Europe Milano - 21 settembre 2007 Global pharmaceutical sales 643 billions US$ in 06 Total world market 16% Growth over previous year 600 14% 500 12% 400 10% 8% 300 6% 200 4% 100 2% 0 0% 1999 In billions USD Total World market % Constant US $ growth 2000 2001 2002 2003 2004 2005 2006 1999 2000 2001 2002 2003 2004 2005 2006 334 362 387 427 498 559 601 643 14.5 11.7 11.8 10.6 10.4 8.0 6.8 7.0 Source: IMS Health, IMS Market Prognosis International, Feb 2007 Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 2 2006: market dynamic is different according to the region Europe Size: $ 182 bn North America Size: $ 290 bn % Growth: 4.8% Japan Size: $ 57 bn % Growth: 8% % Growth: -0.7% Asia/Africa/Australia Latin America Size: $ 52 bn Size:$ 27.5 bn % Growth: 9.8% % Growth: 12.9% Source: IMS Health - Global Pharma Forecasts, March 2007 Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 3 2006: within the region, market dynamic is different according to the country +2.3% Italy +0.5% 15.3 bn $ France Germany 28.5 bn $ +4% +2.6% Top 5 Europe 98.3 bn $ 26.3 bn $ + 6.3% +3.1% Spain UK 11.9 bn $ 16.3 bn $ Source : IMS Health – MIDAS – Retail market Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 4 * : Constant dollar Contribution to growth Emerging market contribute to 27% of the total growth 2001 +25.5 Billions US $ -1 Japan 4 2006 +42.4 Billions US $ 8 8 Rest of the world 27 Emerging markets 13 16 Europe 29 50 US -10 46 0 10 20 30 % CONTRIBUTION Source: IMS Health, IMS Market Prognosis International, Feb 2007 Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 5 40 50 60 Number of Global Blockbusters Number of Blockbusters For the first time, “specialist driven” drugs represent half of the blockbusters 105 110 Specialist driven 100 Primary care driven 90 49% 80 70 60 50 44 40 25% 51% 30 20 75% 10 0 2000 2002 2004 Source: IMS Health, MIDAS, MAT Dec 2006, Market Insights Team research Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 6 2006 Protection status in 5 key markets 100% 90% % Market Share US $ 80% 70% 11 14 4 12 17 6 -22 -28 7 10 -9 -15 60% 50% 40% 14 11 7 -2 12 -22 -20 15 9 30% 16 11 13 20% 10% 0% Total 5 markets US In-Patent Italy France Off-Patent Source: IMS Health, MIDAS, New Market Segmentation, RX only, MAT Dec 2006 Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 7 Generics Germany Other UK Italian retail market: reimbursable drugs Since the 2nd semester 06, a regular decrease of the growth for the units and a negative growth in value* 15,0 10,0 10.3% % growth 5,0 5.9% 4.7% 2.7% 0,0 06 20 H 1 06 20 H 2 - 3.4% 07 20 H 1 -9% -5,0 -10,0 % vs previous (Units) Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 8 % vs. previous (Values) *: in public price Italian retail market: reimbursable drugs In units, the reimbursable market is becoming flat Reimbursable market - in units Units 600 000 000 500 000 000 400 000 000 300 000 000 200 000 000 100 000 000 0 1H2005 2H2005 Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 9 1H2006 2H2006 1H2007 MTH/JUL/07 Italian retail market: reimbursable drugs In value*, the reimbursable market is declining In € Reimbursable market - in value 7 000 000 6 000 000 -9% 5 000 000 4 000 000 3 000 000 2 000 000 1 000 000 0 1H2005 2H2005 1H2006 2H2006 Top 5 Europe: + 2% (1st 07 vs 1st 06) Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 10 1H2007 MTH/JUL/07 *: in public price Italian pharma R&D Growth of pharma R&D investment is higher than the rest of the industry during the last 6 years 10,2 10 9,8 9,6 9,4 9,2 9 8,8 8,6 8,4 2000 2001 2002 2003 2004 2005 2006 % of pharma invest ment on t ot al indust ry R&D investment - in million € Pharma Total Industry 893,9 921,1 883,1 915,0 1 004,7 1 070,0 1 115,0 + 24.7% 9 230,7 9 710,7 9 778,6 9 690,6 10 143,0 10 575,4 10 975,0 + 18.9% Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 11 Italian pharma R&D % of workers in the R&D In % of total employees 9 8 7 6 5 4 3 2 1 0 1999 2000 2001 2002 Pharma 2003 2004 2005 2006 Total Industry Rate of workers in pharma R&D is much more higher than in the industry Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 12 R&D : drugs in active development 750 Italy 1659 1217 Germany France 465 2871 Spain UK Belgium: 401 - Poland : 155 Source : IMS Health – R&D Focus Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 13 Top 10 market rankings to 2010 China just behind the old Europe 2002 2010 1 USA 1 USA 2 JAPON 2 JAPON 3 ALLEMAGNE 3 FRANCE 4 FRANCE 4 ALLEMAGNE 5 ITALIE 5 UK 6 UK 6 ITALIE 7 ESPAGNE 7 CHINE 8 CANADA 8 CANADA 9 BRESIL 9 ESPAGNE 10 CHINE 10 10 countries: +80% of drugs’ consumption (in value) • Italy will be the 6th country in term of drugs’ consumption (in value) • China will be the 7st country in term of drugs’ consumption (in value) • Turkey, South Korea and India will be closed to Top 10 BRESIL Source: IMS Health -IMS Market Prognosis 2002-2010 Il Futuro Dell'Industria Farmaceutica - 21 settembre 2007 14 Thank you very much for your attention …. Daniel VIAL Vicepresidente IMS Europe [email protected]